We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Innovative 3-D Vessel Navigator for Treatment of Vascular Disease Launched

By MedImaging International staff writers
Posted on 05 May 2015
Print article
Image: Philips VesselNavigator (Photo courtesy of Philips Healthcare).
Image: Philips VesselNavigator (Photo courtesy of Philips Healthcare).
New, advanced visualization software that can be used with interventional X-Ray systems to help vascular surgeons guide catheters during treatment of vascular disease has been announced.

The vessel navigator fuses X-ray images of blood vessels with 3-D Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) images and creates 3-D color-coded images of the vessels. The navigator enables minimally invasive treatment of aortic aneurysms and has been shown to reduce contrast medium usage by up to 70% and vascular procedure duration by 18%.

The VesselNavigator was developed by Philips Healthcare (Best, The Netherlands) and was designed for use with Philips’ interventional X-ray systems. Vascular surgeons can use the VesselNavigator to maneuver a catheter, through major blood vessels using image guidance. The surgeon can then position and deploy stents or other implants to reinforce the vessel walls.

Prof. Dr. Frank Vermassen, Head of Vascular and Thoracic Surgery at University Hospital Ghent (Ghent, Belgium), said, “VesselNavigator gives vascular surgeons during endovascular procedures the 3D view of the patient’s anatomy, which they are familiar with from open surgery. It also significantly reduces the amount of contrast medium required, which means a lesser burden on the kidneys. And with a growing population of elderly and diabetic people who suffer from poor kidney function, reducing contrast medium requirements will open up endovascular treatments to a wider range of patients.”

Related Links:

Philips Healthcare
University Hospital Ghent


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80
Color Doppler Ultrasound System
DRE Crystal 4PX
Ultrasound Software
UltraExtend NX

Print article

Channels

MRI

view channel
Image: Diamond dust offers a potential alternative to the widely used contrast agent gadolinium in MRI (Photo courtesy of Max Planck Institute)

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans

Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.